BRIAN MILLER: Open Payments
NPI 1861411381 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,194 in 62 payments from 14 companies in 2025. Trend: 2023 $21,888 · 2024 $24,595 · 2025 $21,194
Speaker / faculty: $9,180Consulting: $7,460Food & beverage: $2,250Travel & lodging: $2,154Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 26 | $18,572 |
| E.R. Squibb & Sons, L.L.C. | 13 | $1,739 |
| Neurocrine BioSciences, Inc. | 7 | $334 |
| H2-Pharma, LLC | 1 | $150 |
| LivaNova USA, Inc. | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $37 |
Products named: LYBALVI, COBENFY, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, Auvelity, FANAPT.
Industry payments across CA — which companies pay providers there.
